Teva Pharmaceuticals · 1 day ago
Intern - Production - Davie, FL
Davie, FL
Internship
Onsite
Intern
Start in 2026 SpringTeva Pharmaceuticals is an international pharmaceuticals company on a mission to make good health more affordable and accessible. The role involves gaining in-depth insight into the Production department and participating in meaningful work and real-life projects over a 13-week internship program.
BiopharmaHealth CareMedicalPharmaceutical
Responsibilities
During the 13 week program, you will gain in-depth insight into the Production department
Supported by a mentor and experienced colleagues, you will be directly involved in our daily business and be assigned tasks within diverse projects
You will also play an important role in the development of concepts and initiatives
You will lead an innovative project aimed to combine traditional manufacturing concepts and fundamentals with new technologies available to you to successfully yield a significant and impactful project that can be quantified in terms of contribution to the Production Department but also look very well on your updated CV
Qualification
Required
Currently enrolled in Mechanical, Biomedical or similar program of Engineering or Sciences
Fundamental understanding and experience in Design tools such as Auto-CAD
Fundamental understanding and experience in Software and AI applications
Currently reside in commutable distance to Davie, FL
Company
Teva Pharmaceuticals
Teva Pharmaceuticals is a pharmaceutical company that develops generic and innovative medicines.
Founded in 1901
10001+ employees
H1B Sponsorship
Teva Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (7)
2024 (4)
2023 (23)
2022 (48)
2021 (31)
2020 (33)
Funding
Current Stage
Public CompanyTotal Funding
$5.51BKey Investors
Royalty PharmaBerkshire Hathaway
2026-01-11Post Ipo Equity· $500M
2025-05-20Post Ipo Debt· $2.3B
2023-11-13Post Ipo Equity· $100M
Leadership Team
Dipankar Bhattacharjee
President & CEO: Generics Europe
Richard Francis
President and Chief Executive Officer
Recent News
2026-01-17
2026-01-14
2026-01-14
Company data provided by crunchbase